US EditionPublished • loading... • Updated
Million-dollar fungal treatment investment | Brimbank & North West
Summary by Star Weekly
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Million-dollar fungal treatment investment | Brimbank & North West
A significant breakthrough in treating one of the world’s most urgent and underestimated health challenges has received a $1 million boost through the La Trobe University Eagle Fund. Deftbiotech, a spin-out company based at La Trobe, has been established to progress the development of a new anti-fungal drug called Pezadeftide. This innovative treatment showed immense promise as a topical solution for fungal nail disease during its initial Phase …
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
